Mythbusting LCS with Patients: Risks Related to Lung Cancer (Part 4)

2021-11-19

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020. In the final part of their discussion, Dr. Debra Dyer, MD, and patient advocate Ron Simmons talk about the risks related to lung cancer. As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “...

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.

In the final part of their discussion, Dr. Debra Dyer, MD, and patient advocate Ron Simmons talk about the risks related to lung cancer.

As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”

Ron Simmons is a cancer survivor and experienced patient advocate. Ron was initially diagnosed with Stage 1 colon cancer through routine colonoscopy in 2013; his diagnosis with Stage 3 lung cancer four years later was decidedly less smooth. As of 2021, Ron still reports that he has no evidence of disease, and additionally was able to remove his chemotherapy port.

Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Comments (3)